Effectiveness of Intensive Aphasia Therapy Under Routine Clinical Conditions
FCET2EC
From Controlled Experimental Trial to Everyday Communication: How Effective is Intensive Aphasia Therapy Under Routine Clinical Conditions?
1 other identifier
interventional
156
1 country
1
Brief Summary
The purpose of this study is to examine whether 3 weeks of intensive language therapy provided in clinical in- and outpatient settings is effective in improving everyday communication in postacute/chronic post-stroke aphasia, as measured by performance on the Amsterdam Nijmegen Everyday Language Test (ANELT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2012
CompletedFirst Posted
Study publicly available on registry
February 28, 2012
CompletedStudy Start
First participant enrolled
April 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedApril 30, 2026
April 1, 2026
2.8 years
February 6, 2012
April 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes on the Amsterdam Nijmegen Everyday Language Test (ANELT) - A-scale
Mean gain in ANELT understandability scores (ANELT A-scale; using the parallel versions ANELT-I and ANELT-II)
Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)
Secondary Outcomes (10)
morbidity measure: changes in language-systematic aphasia screening (SAPS)
Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)
morbidity measure: changes in communicative-pragmatic screening (KOPS)
Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)
morbidity measure: changes in Modified Rankin Scale
Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)
quality of life measure: changes in German version of the Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39)
Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)
quality of life measure: changes in Communicative Effectiveness Index (CETI) and the ANELT partner communication questionnaire
Baseline is compared to performance 6 months post 3 weeks of intensive language therapy.
- +5 more secondary outcomes
Study Arms (2)
Intensive aphasia therapy group
EXPERIMENTALGroup starts intensive integrative aphasia therapy within 3 workdays (or as soon as possible) after baseline exam
Waiting list control group
OTHERGroup starts intensive integrative aphasia therapy after a waiting period of at least three weeks
Interventions
Intensive language therapy (3 weeks, 5 days/week, \>=2 hours/day) provided in regular clinical setting and consisting of a combination of language systematic and communicative-pragmatic treatment
Control group starts intensive language therapy after a 3-week waiting period.
Eligibility Criteria
You may qualify if:
- presence of aphasia for at least 6 months after non-hemorrhagic or hemorrhagic cortical or subcortical-cortical stroke
- native language German
- participant's comprehension ability needs to be sufficiently high to give informed consent
- participant's language abilities have to allow the administration of the Aachen Aphasia Test (AAT)
You may not qualify if:
- aphasia due to non-vascular etiology
- no evidence for aphasia (based on AAT subtests 'Token Test' and 'Written Language'
- severe untreated medical conditions which prohibit participation in intensive language therapy
- severe vision or hearing problems (uncorrected)
- participation in another interventional or language therapy study within four weeks before potential enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fresenius University of Applied Sciencecollaborator
- Entwicklungsgruppe Klinische Neuropsychologie, Klinikum Bogenhausen, Münchencollaborator
- Institut für Biometrie und Klinische Epidemiologie, Charité Campus Benjamin Franklin, Berlincollaborator
- RWTH Aachen Universitycollaborator
- Bundesverband für die Rehabilitation der Aphasiker e.V.collaborator
- Universitätsklinikum Leipzigcollaborator
- MEDIAN Klinik Grünheidecollaborator
- Brandenburgklinik Berlin-Brandenburg GmbHcollaborator
- St. Mauritius Therapieklinikcollaborator
- Aphasie- und Seniorenzentrum Josef Bergmann Vechtacollaborator
- Behandlungs- und Rehabilitationszentrum für Intensiv-Therapie Lindlarcollaborator
- Wickerklinik Bad Homburg v.d.H.collaborator
- Asklepios Neurological Clinic Falkensteincollaborator
- Schoen Clinic Bad Aiblingcollaborator
- m&i-Fachklinik Bad Liebensteincollaborator
- m&i-Fachklinik Enzensbergcollaborator
- m&i-Fachklinik Herzogenaurachcollaborator
- mediclin Klinikum Soltaucollaborator
- Moritz Klinik, Bad Klosterlausnitzcollaborator
- Klinikum Christophsbad, Göppingencollaborator
- P.A.N.-Zentrumcollaborator
- Städtisches Klinikum München, Klinikum Bogenhausencollaborator
- Akademische Praxis für Sprachtherapie / Praxis für Rehabilitationswesen Aschaffenburgcollaborator
- University Hospital Muensterlead
- Charite University, Berlin, Germanycollaborator
Study Sites (1)
University of Muenster
Münster, North Rhine-Westfalia, 48149, Germany
Related Publications (2)
Breitenstein C, Grewe T, Floel A, Ziegler W, Springer L, Martus P, Huber W, Willmes K, Ringelstein EB, Haeusler KG, Abel S, Glindemann R, Domahs F, Regenbrecht F, Schlenck KJ, Thomas M, Obrig H, de Langen E, Rocker R, Wigbers F, Ruhmkorf C, Hempen I, List J, Baumgaertner A; FCET2EC study group. Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting. Lancet. 2017 Apr 15;389(10078):1528-1538. doi: 10.1016/S0140-6736(17)30067-3. Epub 2017 Mar 1.
PMID: 28256356DERIVEDBaumgaertner A, Grewe T, Ziegler W, Floel A, Springer L, Martus P, Breitenstein C. FCET2EC (From controlled experimental trial to = 2 everyday communication): How effective is intensive integrative therapy for stroke-induced chronic aphasia under routine clinical conditions? A study protocol for a randomized controlled trial. Trials. 2013 Sep 23;14:308. doi: 10.1186/1745-6215-14-308.
PMID: 24059983DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Annette Baumgaertner, PhD
Hochschule Fresenius University of Applied Science
- PRINCIPAL INVESTIGATOR
Caterina Breitenstein, PhD
Neurology, University of Muenster
- STUDY DIRECTOR
Agnes Floel, MD
Neurology, Universitätsmedizin Charite, CCM, Berlin
- PRINCIPAL INVESTIGATOR
Wolfram Ziegler, PhD
Clinical Neuropsychology Research Group (EKN), Klinikum Bogenhausen, München
- PRINCIPAL INVESTIGATOR
Tanja Grewe, PhD
Hochschule Fresenius University of Applied Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2012
First Posted
February 28, 2012
Study Start
April 1, 2012
Primary Completion
January 1, 2015
Study Completion
January 1, 2015
Last Updated
April 30, 2026
Record last verified: 2026-04